How can we prevent antimicrobial resistance (AMR) from destabilizing modern medicine? This session brings together biotechnology innovators, healthcare experts, and regulators to explore new trials, novel procurement models, and smarter data sharing. Speakers highlight cutting-edge antimicrobials, diagnostics, and system-wide incentives that can help the world stay ahead of evolving pathogens and protect routine healthcare.

Speakers

• Flemming Kondrasen, Chief Scientific Officer, Novo Nordisk Foundation

• Adèle James, Co-founder & Chief Technology Officer, Phagos

• Steve Clemons, Editor at Large, National Interest

• John Schoonbee, Global Chief Medical Officer, Swiss Re